首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   7273篇
  免费   574篇
  国内免费   33篇
耳鼻咽喉   80篇
儿科学   107篇
妇产科学   174篇
基础医学   938篇
口腔科学   222篇
临床医学   784篇
内科学   1579篇
皮肤病学   145篇
神经病学   634篇
特种医学   671篇
外科学   1358篇
综合类   35篇
预防医学   227篇
眼科学   153篇
药学   317篇
中国医学   2篇
肿瘤学   454篇
  2023年   92篇
  2022年   161篇
  2021年   332篇
  2020年   197篇
  2019年   291篇
  2018年   319篇
  2017年   234篇
  2016年   258篇
  2015年   311篇
  2014年   404篇
  2013年   401篇
  2012年   610篇
  2011年   607篇
  2010年   364篇
  2009年   356篇
  2008年   427篇
  2007年   414篇
  2006年   325篇
  2005年   296篇
  2004年   238篇
  2003年   233篇
  2002年   165篇
  2001年   84篇
  2000年   62篇
  1999年   78篇
  1998年   27篇
  1997年   36篇
  1996年   24篇
  1995年   11篇
  1994年   13篇
  1993年   12篇
  1992年   23篇
  1991年   26篇
  1990年   15篇
  1989年   19篇
  1988年   25篇
  1987年   23篇
  1986年   27篇
  1985年   24篇
  1984年   13篇
  1983年   12篇
  1982年   10篇
  1981年   13篇
  1979年   23篇
  1975年   12篇
  1932年   13篇
  1931年   8篇
  1929年   7篇
  1924年   12篇
  1922年   8篇
排序方式: 共有7880条查询结果,搜索用时 15 毫秒
81.
82.
Prostate cancer is the most common malignancy, accounting for about 25% of all incident cases among men in industrialized countries. The human androgen-dependent prostate cancer cell line LNCaP, which is derived from a metastatic lesion of human prostatic adenocarcinoma, is frequently used to study prostate cancer associated signaling pathways in vitro. Recently it was described that Rho GTPase activation in these cells leads to apoptotic responses. We used the bacterial toxins CNFy and CNF1, which specifically and directly activate Rho GTPases by deamidation of a single glutamine. We asked whether these Rho activators could induce apoptosis in LNCaP cells. Our results indicate that RhoA activation, induced by CNFy, does lead to intrinsic apoptosis of the cells. Analysis of the underlying signaling pathway reveals that apoptosis induction requires the activity of Rho kinase (ROCK) and myosin activation, an apoptotic pathway previously identified in cancer stem cells.  相似文献   
83.
84.
Facial fillers play an important role in the correction of facial changes associated with ageing. They offer quick treatments in the outpatient setting with minimal subsequent downtime that provide predictable, natural‐looking, long‐lasting results. Adverse reactions after hyaluronic acid injections tend to be mild or moderate and rather temporary. However, as with all injected or implanted biomaterials, severe adverse events can occur and patients must be fully informed of potential risks prior to undergoing treatment. A panel of experts from Germany (D), Austria (A) and Switzerland (CH) developed recommendations, and this study provides the ‘DACH Consensus Recommendations’ from this group specifically on the use of hyaluronic acid fillers. The aim is to help clinicians recognize potential risks and to provide guidance on how best to treat adverse events if they arise. Contraindications to hyaluronic acid fillers are also detailed, and ways to prevent adverse events occurring are discussed. Hyaluronic acid‐based products are claimed to be very close to an ideal tissue augmentation agent; nevertheless, profound medical, anatomical and product knowledge are of paramount importance to minimize the occurrence of adverse reactions.  相似文献   
85.
Efficient removal of biofilms from medical devices is a big challenge in health care to avoid hospital-acquired infections, especially from delicate devices like flexible endoscopes, which cannot be reprocessed using harsh chemicals or high temperatures. Therefore, milder solutions such as enzymatic cleaners have to be used, which need to be carefully developed to ensure efficacious performance. In vitro biofilm in a 96-well-plate system was used to select and optimize the formulation of novel enzymatic cleaners. Removal of the biofilm was quantified by crystal violet staining, while the disinfecting properties were evaluated by a BacTiter-Glo assay. The biofilm removal efficacy of the selected cleaner was further tested by using European standard (EN) for endoscope cleaning EN ISO 15883, and removal of artificial blood soil was investigated by treating TOSI (Test Object Surgical Instrument) cleaning indicators. Using the process described here, a novel enzymatic endoscope cleaner was developed, which removed 95% of Staphylococcus aureus and 90% of Pseudomonas aeruginosa biofilms in the 96-well plate system. With a >99% reduction of CFU and a >90% reduction of extracellular polymeric substances, this cleaner enabled subsequent complete disinfection and fulfilled acceptance criteria of EN ISO 15883. Furthermore, it efficiently removed blood soil and significantly outperformed comparable commercial products. The cleaning performance was stable even after storage of the cleaner for 6 months. It was demonstrated that incorporation of appropriate enzymes into the cleaner enhanced performance significantly.  相似文献   
86.
87.
88.
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号